RxSight Q3 Adj. EPS $(0.21) Beats $(0.29) Estimate, Sales $24.586M Miss $27.137M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings BeatsEarnings Misses
RxSight (NASDAQ:RXST) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.29) by 27.59 percent. This is a 425 percent decrease over losses of $(0.04) per share from the same
RxSight (NASDAQ:RXST) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.29) by 27.59 percent. This is a 425 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $24.586 million which missed the analyst consensus estimate of $27.137 million by 9.40 percent. This is a 18.86 percent decrease over sales of $30.300 million the same period last year.